Mineralys Therapeutics Statistics

Total Valuation

MLYS has a market cap or net worth of $883.78 million. The enterprise value is $540.75 million.

Market Cap	883.78M
Enterprise Value	540.75M

Important Dates

The last earnings date was Tuesday, August 12, 2025, after market close.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

MLYS has 65.18 million shares outstanding. The number of shares has increased by 25.20% in one year.

Current Share Class	65.18M
Shares Outstanding	65.18M
Shares Change (YoY)	+25.20%
Shares Change (QoQ)	+23.11%
Owned by Insiders (%)	1.71%
Owned by Institutions (%)	76.63%
Float	43.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.58
P/TBV Ratio	2.59
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-40.19%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$3.74M
Employee Count	51
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +19.58% in the last 52 weeks. The beta is -0.30, so MLYS's price volatility has been lower than the market average.

Beta (5Y)	-0.30
52-Week Price Change	+19.58%
50-Day Moving Average	14.18
200-Day Moving Average	13.13
Relative Strength Index (RSI)	47.75
Average Volume (20 Days)	777,521

Short Selling Information

The latest short interest is 7.00 million, so 10.74% of the outstanding shares have been sold short.

Short Interest	7.00M
Short Previous Month	7.87M
Short % of Shares Out	10.74%
Short % of Float	16.05%
Short Ratio (days to cover)	10.35

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-203.07M
Pretax Income	-90.80M
Net Income	-190.77M
EBITDA	-203.01M
EBIT	-203.07M
Earnings Per Share (EPS)	-$3.49

Full Income Statement

Balance Sheet

The company has $343.03 million in cash and n/a in debt, giving a net cash position of $343.03 million or $5.26 per share.

Cash & Cash Equivalents	343.03M
Total Debt	n/a
Net Cash	343.03M
Net Cash Per Share	$5.26
Equity (Book Value)	341.56M
Book Value Per Share	5.26
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MLYS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.20%
Shareholder Yield	-25.20%
Earnings Yield	-21.59%
FCF Yield	n/a

Analyst Forecast

The average price target for MLYS is $27.00, which is 99.12% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$27.00
Price Target Difference	99.12%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a